Zobrazeno 1 - 10
of 185
pro vyhledávání: '"JOSIP BEGOVAC"'
Autor:
Josip Begovac
Publikováno v:
The Lancet Regional Health. Europe, Vol 47, Iss , Pp 101130- (2024)
Externí odkaz:
https://doaj.org/article/42125b0725864356ba41faab5d458ca2
Autor:
Irina Ianache, Agata Skrzat-Klapaczynska, David Jilich, Lukas Fleischhans, Ivana Gmizic, Jovan Ranin, Antonios Papadopoulos, Konstantinos Protopapas, Velida Mulabdic, Botond Lakatos, Eva Livia Nagy, Josip Begovac, Tiberiu Holban, Dilek Yildiz Sevgi, Alma Cicic, Nina Yancheva, Lubomir Sojak, Nino Rukhadze, Justyna Kowalska, Cristiana Oprea
Publikováno v:
Travel Medicine and Infectious Disease, Vol 59, Iss , Pp 102719- (2024)
Background: The aim of the study was to assess socio-demographical characteristics, clinical presentation, and outcomes in patients diagnosed with mpox. Methods: A survey on patients diagnosed with mpox was performed in 14 countries from Central and
Externí odkaz:
https://doaj.org/article/b7a02dd00dc043769b4c9343ace59ad7
Autor:
Josip Begovac, Vanja Romih Pintar, Nina Vrsaljko, Loris Močibob, Nikolina Bogdanić, Šime Zekan, Oktavija Đaković Rode
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract We conducted a nationwide longitudinal observational study to estimate the incidence of syphilis in a cohort of male persons living with HIV (MLWH) in Croatia in the pre-COVID-19 and COVID-19 years. Data were reviewed and extracted from the
Externí odkaz:
https://doaj.org/article/bd9f63cefc05410ab593e69eaad8a7fa
Autor:
Ana Planinić, Josip Begovac, Filip Rokić, Petra Šimičić, Maja Oroz, Katja Jakovac, Oliver Vugrek, Snjezana Zidovec-Lepej
Publikováno v:
Viruses, Vol 15, Iss 12, p 2408 (2023)
Molecular epidemiology of HIV-1 infection is challenging due to the highly diverse HIV-genome. We investigated the genetic diversity and prevalence of transmitted drug resistance (TDR) followed by phylogenetic analysis in 270 HIV-1 infected, treatmen
Externí odkaz:
https://doaj.org/article/3e5626a2cabc4a6cb33a9f748882100b
Publikováno v:
Acta Clinica Croatica, Vol 61., Iss 1., Pp 11-17 (2022)
The aim of this study was to characterize and compare changes in subcutaneous fat in the malar, brachial and crural region in a cohort of HIV-infected patients taking antiretroviral therapy. This prospective longitudinal study included 77 patients
Externí odkaz:
https://doaj.org/article/aae6d206a3594e9b835138f976a5c617
Autor:
Annegret Pelchen-Matthews, Jakob Friis Larsen, Leah Shepherd, Josip Begovac, Karen Pedersen, Stéphane De Wit, Andrzej Horban, Elzbieta Jablonowska, Margaret Johnson, Irina Khromova, Marcelo H. Losso, Lars N. Nielsen, Anna Lisa Ridolfo, Brigitte Schmied, Christoph Stephan, Israel Yust, Lloyd Curtis, Vani Vannappagari, Leigh Ragone, Ashley Roen, Dorthe Raben, Ole Kirk, Lars Peters, Amanda Mocroft, for the EuroSIDA Study Group
Publikováno v:
HIV Research & Clinical Practice, Vol 22, Iss 6, Pp 160-168 (2021)
Background: Hypersensitivity reaction (HSR) and hepatotoxicity are rare, but potentially serious side-effects of antiretroviral use. Objective: To investigate discontinuations due to HSR, hepatotoxicity or other reasons among users of dolutegravir (D
Externí odkaz:
https://doaj.org/article/19ba791aac3342e2ac27b1f0aef3c856
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract We assessed the prevalence and factors related to the time to antiretroviral (ART) initiation among persons who entered HIV care and subsequently started ART in Croatia from 2005 to 2014. Included were patients ≥ 18 years, the follow-up en
Externí odkaz:
https://doaj.org/article/17695de0b5634c5c822b97f32e44e657
Autor:
Kerstin Aimla, Justyna Dominika Kowalska, Raimonda Matulionyte, Velida Mulabdic, Anna Vassilenko, Natalie Bolokadze, David Jilich, Sergii Antoniak, Cristiana Oprea, Tatevik Balayan, Arjan Harxhi, Antonios Papadopoulos, Botond Lakatos, Marta Vasylyev, Josip Begovac, Nina Yancheva, Anca Streinu-Cercel, Antonija Verhaz, Deniz Gokengin, Gordana Dragovic, Lubomir Sojak, Agata Skrzat-Klapaczyńska
Publikováno v:
Vaccines, Vol 11, Iss 5, p 980 (2023)
(1) Background: Viral hepatitis C (HCV) and viral hepatitis B (HBV) are common co-infections in people living with HIV (PLWH). All PLWH should be vaccinated against HBV and hepatitis A (HAV) and treated for HBV and HCV. We aimed to compare testing, p
Externí odkaz:
https://doaj.org/article/72ed06cdd3e3422c933b5e53b999a76d
Publikováno v:
PLoS ONE, Vol 17, Iss 7 (2022)
Externí odkaz:
https://doaj.org/article/9514fe8184094639a07fd5d25052a75a
Autor:
Deniz Gokengin, Dominik Bursa, Agata Skrzat-Klapaczynska, Ivailo Alexiev, Elena Arsikj, Tatevik Balayan, Josip Begovac, Alma Cicic, Gordana Dragovic, Arjan Harxhi, Kerstin Aimla, Botond Lakatos, Raimonda Matulionyte, Velida Mulabdic, Cristiana Oprea, Antonios Papadopoulos, Nino Rukhadze, Dalibor Sedlacek, Lubomir Sojak, Janez Tomazic, Anna Vassilenko, Marta Vasylyev, Antonija Verhaz, Nina Yancheva, Oleg Yurin, Justyna Kowalska
Publikováno v:
Vaccines, Vol 11, Iss 1, p 122 (2023)
With no expected vaccine for HIV in the near future, we aimed to define the current situation and challenges for pre- and post-exposure prophylaxis (PrEP and PEP) in Central and Eastern Europe (CEE). The Euroguidelines CEE Network Group members were
Externí odkaz:
https://doaj.org/article/d725f3ceb6ef4fa8b885191f4ff8aec3